Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine April 2006, 47 (4) 9a-10a;
  • Article
  • Info & Metrics
  • PDF
Loading

Gambhir reviews the use of aptamers as novel imaging probes and previews an article in this issue of JNM on tumor targeting in a small-animal model.
Page 557

Figure

Prévost and colleagues evaluate the effectiveness of 18F-FDG PET measures of diffuse bone marrow hypermetabolism and other factors in predicting outcomes in patients with non–small cell lung cancer.
Page 559

Meisetschläger and colleagues compare the pharmacokinetics, biodistribution, and diagnostic performance of a recently introduced 18F-labeled PET tracer for somatostatin receptor (sstr) imaging with 111In-DTPA-octreotide in a population of patients with sstr-positive tumors.
Page 566

Beeres and colleagues use both 99mTc-tetrofosmin SPECT and 18F-FDG SPECT to investigate the effects of autologous bone marrow–derived mononuclear cell injection into the myocardium of patients with drug-refractory ischemia.
Page 574

Moore and colleagues apply whole-body and static γ-camera imaging to evaluate the accuracy of measurements of whole-skeleton 99mTc-MDP plasma clearance obtained using the area-under-the-curve method.
Page 581

Bar-Shalom and colleagues explore the role of SPECT/CT as an adjunct to 67Ga scintigraphy or 111In-labeled white blood cell scintigraphy for diagnosis or localization of suspected infection.
Page 587

Funk and colleagues report on a novel multipinhole collimator to improve detection efficiency in cardiac SPECT and detail significant advantages over rotational SPECT with conventional parallel-hole collimators.
Page 595

Engles and colleagues describe a transient “stunning” effect after chemotherapy for breast cancer and discuss potential implications for 3H-FDG PET imaging.
Page 603

Choi and colleagues assess whether 18F-FDG uptake patterns and CT findings improve accuracy over standardized uptake values alone in differentiating benign from malignant focal thyroid lesions incidentally found on 18F-FDG PET/CT.
Page 609

Palmedo and colleagues document the diagnostic accuracy and effect on patient management of PET/CT in patients with suspected iodine-negative, differentiated thyroid carcinoma and compare these results with those obtained by side-by-side interpretation of PET and CT images.
Page 616

Figure

Dumarey and colleagues investigate the feasibility and potential role of PET/CT with 18F-FDG–labeled autologous leukocytes in the diagnosis and localization of infectious lesions in patients with suspected or documented bacterial infections or with fevers of unknown origin.
Page 625

Figure

Nishiyama and colleagues evaluate the efficacy of dual-time-point 18F-FDG PET imaging for differentiating malignant from benign gallbladder disease and discuss the limitations and benefits of this approach.
Page 633

Pichler and colleagues describe the initial development of a lutetium oxyorthosilicate–avalanche photodiode array detector PET module to be combined with a 7-T MRI system for high-resolution PET/MRI in small animals.
Page 639

Hänscheid and colleagues report on an international study of postoperative radioiodine ablation therapy with 3.7 GBq of 131I in differentiated thyroid cancer after stimulation with recombinant human thyroid-stimulating hormone or after thyroid hormone withdrawal.
Page 648

Stabin and colleagues provide dose factors for internal sources in realistic, segmented, voxel-based models of a typical mouse and typical rat, based on image data obtained using a dedicated small-animal CT scanner.
Page 655

Figure

Madsen and colleagues devise a theoretical model to investigate the potential incremental value of combined-agent 131I-MIBG and 90Y-DOTATOC therapy in neuroendocrine tumors.
Page 660

Hicke and colleagues describe a novel approach to assess whether aptamers, small oligonucleotides with the potential to bind tightly to targeted molecules, have potential for in vivo delivery of radioisotopes or cytotoxic agents.
Page 668

Tsukada and colleagues compare the tumor imaging capabilities of the l- and d-isomers of 11C-CMT and 18F-FMT with corresponding 11C-MET isomers and discuss the potential implications of their results for imaging of cerebral and peripheral tumors.
Page 679

Welch and colleagues report on a study to determine whether kinetic modeling in conjunction with small-animal PET can noninvasively quantify alterations in myocardial perfusion and substrate metabolism in a rat model.
Page 689

Figure
Figure

Ametamey and colleagues evaluate 11C-ABO688, a novel antagonist for the metabotropic glutamate receptor subtype 5, as a PET imaging agent in a mouse brain model and point to potential applications in diagnosis and therapy.
Page 698

Yaghoubi and colleagues present the results of a toxicity evaluation of FHBG, which, when labeled with 18F, is a sensitive and specific PET reporter probe for imaging hepatocellular cancer and has been approved as an Investigational New Drug.
Page 706

Kelly and colleagues explore the biodistribution and therapeutic efficacy of a combined 90Y-labeled monoclonal antibody and paclitaxel regimen in a mouse model of breast cancer.
Page 716

ON THE COVER

A 58-y-old patient who had been treated 2 y earlier with total thyroidectomy and ablative radioiodine for oxyphilic follicular thyroid carcinoma presented with a markedly elevated thyroglobulin level but no iodine accumulation. Fine-needle aspiration biopsy of a suggestive cervical lymph node revealed tumor cells. Preoperative PET showed intense 18F-FDG uptake in that lymph node, as demonstrated in a coronal slice (top). However, on a transverse slice (second from top), PET detected a second tumor that was more caudal and for which the CT image (third from top) revealed no corresponding abnormality. Only by fusion of the PET and CT images (bottom) could the second tumor be precisely localized and surgically removed.

Figure

SEE PAGE 621

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (4)
Journal of Nuclear Medicine
Vol. 47, Issue 4
April 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Apr 2006, 47 (4) 9a-10a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Apr 2006, 47 (4) 9a-10a;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Using Radiolabeled DNA as an Imaging Agent to Recognize Protein Targets
  • Bone Marrow Hypermetabolism on 18F-FDG PET as a Survival Prognostic Factor in Non–Small Cell Lung Cancer
  • Gluc-Lys([18F]FP)-TOCA PET in Patients with SSTR-Positive Tumors: Biodistribution and Diagnostic Evaluation Compared with [111In]DTPA-Octreotide
  • Effect of Intramyocardial Injection of Autologous Bone Marrow–Derived Mononuclear Cells on Perfusion, Function, and Viability in Patients with Drug-Refractory Chronic Ischemia
  • Validation of a Blood-Sampling Method for the Measurement of 99mTc-Methylene Diphosphonate Skeletal Plasma Clearance
  • SPECT/CT Using 67Ga and 111In-Labeled Leukocyte Scintigraphy for Diagnosis of Infection
  • A Novel Approach to Multipinhole SPECT for Myocardial Perfusion Imaging
  • Stunning and Its Effect on 3H-FDG Uptake and Key Gene Expression in Breast Cancer Cells Undergoing Chemotherapy
  • Focal Thyroid Lesions Incidentally Identified by Integrated 18F-FDG PET/CT: Clinical Significance and Improved Characterization
  • Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management
  • Imaging Infection with 18F-FDG–Labeled Leukocyte PET/CT: Initial Experience in 21 Patients
  • Dual-Time-Point 18F-FDG PET for the Evaluation of Gallbladder Carcinoma
  • Performance Test of an LSO-APD Detector in a 7-T MRI Scanner for Simultaneous PET/MRI
  • Iodine Biokinetics and Dosimetry in Radioiodine Therapy of Thyroid Cancer: Procedures and Results of a Prospective International Controlled Study of Ablation After rhTSH or Hormone Withdrawal
  • Voxel-Based Mouse and Rat Models for Internal Dose Calculations
  • Potential Increased Tumor-Dose Delivery with Combined 131I-MIBG and 90Y-DOTATOC Treatment in Neuroendocrine Tumors: A Theoretic Model
  • Tumor Targeting by an Aptamer
  • Evaluation of d-Isomers of O-11C-Methyl Tyrosine and O-18F-Fluoromethyl Tyrosine as Tumor-Imaging Agents in Tumor-Bearing Mice: Comparison with l- and d-11C-Methionine
  • Assessment of Myocardial Metabolism in Diabetic Rats Using Small-Animal PET: A Feasibility Study
  • Radiosynthesis and Preclinical Evaluation of 11C-ABP688 as a Probe for Imaging the Metabotropic Glutamate Receptor Subtype 5
  • Preclinical Safety Evaluation of 18F-FHBG: A PET Reporter Probe for Imaging Herpes Simplex Virus Type 1 Thymidine Kinase (HSV1-tk) or Mutant HSV1-sr39tk's Expression
  • Enhanced Efficacy of 90Y-Radiolabeled Anti-Lewis Y Humanized Monoclonal Antibody hu3S193 and Paclitaxel Combined-Modality Radioimmunotherapy in a Breast Cancer Model
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire